Key facts
- Notable investors include Proxima Ventures (China), Suzhou Angel Fund of Funds, Noah Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Intellizon
- ·The full record, as it builds
Funding rounds
No funding rounds for Intellizon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Intellizon
Developer of medical technology solutions designed for patients with neurological impairments. The company offers advanced brain-computer interface systems and artificial intelligence technologies, featuring applications in brain science, robotics, and brain-like intelligence, enabling individuals with conditions such as amyotrophic lateral sclerosis and spinal cord injuries to regain functional abilities.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2024
- Website
- intellizonmed.com/
- Ownership
- Privately Held (backing)
Intellizon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Intellizon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Intellizon in its N-PORT filings yet. We sweep new filings monthly.